Crossmark

Atrial to brain natriuretic peptide ratio as a marker of atrial remodeling severity and post-ablation recurrence risk in atrial fibrillation patients with left atrial enlargement

Crossref DOI link: https://doi.org/10.1007/s10840-025-02157-x

Published Online: 2025-10-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamada, Shinya https://orcid.org/0000-0001-5726-3926
Kaneshiro, Takashi

Nodera, Minoru

Amami, Kazuaki

Murota, Sadahiro

Oikawa, Masayoshi

Ishida, Takafumi

Takeishi, Yasuchika
License Information

Text and Data Mining valid from 2025-10-13

Version of Record valid from 2025-10-13
More Information

Article History

Received: 23 June 2025

Accepted: 1 October 2025

First Online: 13 October 2025

Declarations

:

: The study protocol was approved by the ethics committee of Fukushima Medical University (approval number: 2020 − 311).

: Informed consent was obtained from all individual participants included in the study.

: S.Y. and T.I. belong to the Department of Arrhythmia and Cardiac Pacing, which is supported by Abbott Medical Japan LLC, Biotronik Japan, Inc, and Japan Lifeline Co., Ltd. These companies are not associated with the contents of this study. The other authors report no conflicts of interest.

Document is current

Any future updates will be listed below